The animal carcinogenicity evidence is no longer reasonably dismissible
RF Safe argues that animal evidence for RF-related carcinogenicity is now strong and should not be dismissed, citing the NTP (2018) and Ramazzini (2018) lifetime rodent studies as showing statistically significant increases in the same rare tumor types (heart schwannomas and brain gliomas). The post further claims that effects occurred at relatively low whole-body SAR levels and references additional mechanistic hypotheses (e.g., VGCC-related models and radical-pair/spin effects) and a reported human ultrasound observation of acute non-thermal changes. These points are presented as supporting a shift away from a “thermal-only” interpretation, but the item is advocacy/commentary and does not provide full methodological details in the excerpt.
Key points
- Claims two independent GLP-compliant lifetime rodent studies (NTP 2018 and Ramazzini 2018) found statistically significant increases in the same rare tumors: malignant schwannomas of the heart and malignant gliomas of the brain.
- States Ramazzini exposures extended to low whole-body SARs (described as environmental/base-station levels) and emphasizes non-monotonic dose-response patterns.
- Asserts a WHO-commissioned systematic review rated the animal evidence as high-certainty (details not provided in the excerpt).
- Highlights proposed non-thermal mechanisms, including a VGCC-based model attributed to Panagopoulos and radical-pair/spin effects in heme/flavin systems.
- Claims recent human ultrasound documentation shows an acute, reversible biophysical change (RBC rouleaux) after ordinary smartphone exposure, citing a 2025 paper (as described by the source).
Referenced studies & papers
AI-generated summaries may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.
Comments
Log in to comment.
No comments yet.